Cargando…
Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes
The long-term objective of this project is to utilize the I-domain protein for the α-subunit of LFA-1 to target drugs to lymphocytes by binding to ICAM receptors on the cell surface. The short-term goal is to provide proof-of-concept that I-domain conjugated to small molecules can still bind to and...
Autores principales: | Manikwar, Prakash, Tejo, Bimo A., Shinogle, Heather, Moore, David S., Zimmerman, Tahl, Blanco, Francisco, Siahaan, Teruna J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100608/ https://www.ncbi.nlm.nih.gov/pubmed/21611107 |
Ejemplares similares
-
Evaluation of LFA-1 Peptide-Methotrexate Conjugates in Modulating Endothelial Cell Inflammation and Cytokine Regulation
por: Yusuf-Makagiansar, Helena, et al.
Publicado: (2023) -
Divalent cation regulation of the function of the leukocyte integrin LFA-1
Publicado: (1992) -
Direction of actin flow dictates integrin LFA-1 orientation during leukocyte migration
por: Nordenfelt, Pontus, et al.
Publicado: (2017) -
Coordinated Redistribution of Leukocyte LFA-1 and Endothelial Cell ICAM-1 Accompany Neutrophil Transmigration
por: Shaw, Sunil K., et al.
Publicado: (2004) -
LFA1 Activation: Insights from a Single-Molecule Approach
por: Kondo, Naoyuki, et al.
Publicado: (2022)